An April 2014 study published in PLOS One reviewed the possible impact of copper-enhanced disulfiram on pleural mesothelioma cells. Research on the impact of the medication was conducted at the Karmanos Cancer Institute at Wayne University, and the findings showed that the drug could potentially be effective at treating mesothelioma.
The medication has actually been approved by the FDA since the 1950s as a method of treating addiction to alcohol. This recent research provides hope that the medication could be used to localize mesothelioma and prevent the spread of cancer throughout the body. This could help to prolong life and could prove effective at helping mesothelioma patients, who are currently faced with a poor long-term prognosis as mesothelioma is one of the most difficult cancers to treat.
Continue reading